Clinical Utility of Deutetrabenazine as a Treatment Option for Chorea Associated with Huntington’s Disease and Tardive Dyskinesia

Samuel Frank,1 Aljoharah Alakkas2 1Department of Neurology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, USA; 2Department of Neurology, National Neuroscience Institute, King Fahad Medical City, Riyadh, K.S.ACorrespondence: Samuel Frank, Department of Neurology, Beth Israe...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Frank S, Alakkas A
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Dove Medical Press 2023-12-01
Serie:	Therapeutics and Clinical Risk Management
Soggetti:	chorea tardive dyskinesia hyperkinetic movement disorders vmat2 inhibitors
Accesso online:	https://www.dovepress.com/clinical-utility-of-deutetrabenazine-as-a-treatment-option-for-chorea--peer-reviewed-fulltext-article-TCRM
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!